Guangzhou Women and Children's Medical Center Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2014
NCT02244515
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

dexmedetomidine (precedex) (2 trials)

sufentanil (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cerebral Palsy (Phase 4)

Hypertrophy (Phase 4)

Pain, Postoperative (Phase 4)

Tonsillitis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 2